Authors
Ajai Chari, MD, is an expert in hematologic oncology who cares for patients at University of California San Francisco Health.
Mark F. Pyfer, MD, is a board-certified ophthalmic surgeon at Northern Ophthalmic Associates in Jenkintown, Pennsylvania. He is also on the volunteer teaching faculty and medical staff at Wills Eye Hospital and Thomas Jefferson University. This commentary represents his own personal opinion.
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
5 Things to Know About the Oral GLP-1 Era
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5





